New Drug Offers Hope in Relapsed Leukemia

A new drug has been found to show promise in targeting the mutations of acute myeloid leukemia (AML), finds a new study at the Perelman School of Medicine at the University of Pennsylvania and Penn''s Abramson Cancer Center.

Related Links

ASK A DOCTOR ONLINE